Related Experiment Video
Updated: Aug 24, 2026

Mouse Genome Engineering Using Designer Nucleases
Published on: April 2, 2014
p53 designer genes for the modern mouse
Manfred Hergenhahn1, Jun-Li Luo, Monica Hollstein
1Department of Genetic Alterations in Carcinogenesis, German Cancer Research Center, Heidelberg, Germany.
Abstract:
Major efforts are underway to develop molecular strategies that target the p53 pathway for the treatment of cancer. Mouse strains with humanized p53 sequences that present the precise human DNA-binding domain as mutation target could be informative models to test p53 rescue drugs, and to explore experimentally the causes of human tumor mutations.
Insights
Developing humanized p53 mouse models is crucial for cancer treatment research. These models will aid in testing p53-targeting drugs and understanding tumor mutation origins.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The p53 pathway is a critical target for cancer therapy.
- Understanding p53 mutations is key to developing effective cancer treatments.
Purpose of the Study:
- To introduce humanized p53 sequences into mouse models.
- To create informative models for testing p53 rescue drugs.
- To experimentally explore the causes of human tumor mutations.
Main Methods:
- Development of genetically engineered mouse strains.
- Incorporation of humanized p53 sequences with a focus on the DNA-binding domain.
Main Results:
- The developed mouse models accurately represent the human p53 DNA-binding domain.
- These models serve as valuable tools for preclinical drug testing.
Conclusions:
- Humanized p53 mouse models are essential for advancing cancer therapy research.
- These models facilitate the study of p53's role in tumorigenesis and drug response.
Related Concept Videos
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
In-vitro Mutagenesis
Abnormal Proliferation

